FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: BYD, JD.com-Backed PaXini Technology Mulls Hong Kong IPO

By

PaXini Technology, a Chinese developer of dexterous robotic hands and humanoid robots, is weighing an initial public offering in Hong Kong, Bloomberg News reported Wednesday, citing people familiar with the matter.

The BYD (HKG:1211, SHE:002594)- and JD.com (HKG:9618)-backed company is working with advisers and could submit a listing application in the coming months, according to the report.

Key details, including the size and timing of the offering, are still under discussion and have yet to be finalized, Bloomberg said.

PaXini raised more than 1 billion yuan in a March funding round, valuing the company at more than 10 billion yuan, the report added.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Shui-Mu International Chairman Takes on Additional Role of President

Shui-Mu International's (TPE:8443) board appointed Chairman Lo Jung-Yueh to concurrently serve as president, effective Tuesday, according to a same-day Taiwan Exchange filing.The footwear and lifestyle retailer said the appointment replaces former president Kuo Hsin-Yi.

$TPE:8443
Asia

Market Chatter: OYO Operator PRISM Receives SEBI Approval for Planned IPO

Hospitality technology company PRISM has received Securities and Exchange Board of India's approval for its proposed initial public offering, Mint reported Tuesday, citing people familiar with the matter.The OYO operator confidentially filed its draft red herring prospectus with SEBI in December 2025 after shareholders approved a plan to raise up to 66.5 billion rupees through a fresh issue of shares, the report said, citing the sources.PRISM is seeking a valuation of about $7 billion to $8 billion for the proposed offering, Mint noted.The company is expected to publicly file an updated draft prospectus by early July, after which the document will be open for public comments, the report said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$^BSE$^NSEI
Asia

Market Chatter: Genscript Biotech Defends Operations Amid Renewed U.S. Lawmaker Scrutiny

Genscript Biotech (HKG:1548) defended its operations after renewed scrutiny from U.S. lawmakers over alleged national security concerns, the South China Morning Post reported Wednesday.The company said it operates with transparency across its global markets and follows strict data security and intellectual property safeguards, according to the report.The response came after two U.S. lawmakers reportedly sent a letter to the Federal Bureau of Investigation and the Office of the Director of National Intelligence for updated information regarding GenScript and its affiliates.The lawmakers had made a similar request last year, citing concerns about potential links to China's biotechnology ambitions.Shares of the life sciences firm were up over 14% in Wednesday afternoon trade.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$HKG:1548